Aurer, I.; Jakšić, O.; Bašić-Kinda, S.; Mrđenović, S.; Ostojić-Kolonić, S.; Lozić, D.; Holik, H.; Novaković-Coha, S.; Berneš, P.; Krečak, I.;
et al. Treatment-Related Risk Factors for Adverse Outcomes of COVID-19 in Patients Treated for Lymphoid Malignancies in the Pre-Omicron Era—A Study of KroHem, the Croatian Group for Hematologic Diseases. Biomedicines 2024, 12, 331.
https://doi.org/10.3390/biomedicines12020331
AMA Style
Aurer I, Jakšić O, Bašić-Kinda S, Mrđenović S, Ostojić-Kolonić S, Lozić D, Holik H, Novaković-Coha S, Berneš P, Krečak I,
et al. Treatment-Related Risk Factors for Adverse Outcomes of COVID-19 in Patients Treated for Lymphoid Malignancies in the Pre-Omicron Era—A Study of KroHem, the Croatian Group for Hematologic Diseases. Biomedicines. 2024; 12(2):331.
https://doi.org/10.3390/biomedicines12020331
Chicago/Turabian Style
Aurer, Igor, Ozren Jakšić, Sandra Bašić-Kinda, Stefan Mrđenović, Slobodanka Ostojić-Kolonić, Dominik Lozić, Hrvoje Holik, Sabina Novaković-Coha, Petra Berneš, Ivan Krečak,
and et al. 2024. "Treatment-Related Risk Factors for Adverse Outcomes of COVID-19 in Patients Treated for Lymphoid Malignancies in the Pre-Omicron Era—A Study of KroHem, the Croatian Group for Hematologic Diseases" Biomedicines 12, no. 2: 331.
https://doi.org/10.3390/biomedicines12020331
APA Style
Aurer, I., Jakšić, O., Bašić-Kinda, S., Mrđenović, S., Ostojić-Kolonić, S., Lozić, D., Holik, H., Novaković-Coha, S., Berneš, P., Krečak, I., Morić-Perić, M., Narančić, M., Mitrović, Z., & Valković, T.
(2024). Treatment-Related Risk Factors for Adverse Outcomes of COVID-19 in Patients Treated for Lymphoid Malignancies in the Pre-Omicron Era—A Study of KroHem, the Croatian Group for Hematologic Diseases. Biomedicines, 12(2), 331.
https://doi.org/10.3390/biomedicines12020331
